Martine Rothblatt
2018
In 2018, Martine Rothblatt earned a total compensation of $16M as Chairman and Chief Executive Officer at United Therapeutics, a 57% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,021,250 |
|---|---|
| Option Awards | $12,796,803 |
| Salary | $1,208,447 |
| Other | $9,800 |
| Total | $16,036,300 |
Rothblatt received $12.8M in option awards, accounting for 80% of the total pay in 2018.
Rothblatt also received $2M in non-equity incentive plan, $1.2M in salary and $9.8K in other compensation.
Rankings
In 2018, Martine Rothblatt's compensation ranked 276th out of 14,244 executives tracked by ExecPay. In other words, Rothblatt earned more than 98.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 276 out of 14,244 | 98th |
Division Manufacturing | 94 out of 5,765 | 98th |
Major group Chemicals And Allied Products | 31 out of 2,128 | 99th |
Industry group Drugs | 26 out of 1,817 | 99th |
Industry Pharmaceutical Preparations | 18 out of 1,391 | 99th |
Source: SEC filing on April 29, 2019.
Rothblatt's colleagues
We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2018.